Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHE:002399)
China · Delayed Price · Currency is CNY 11.68
+0.29 (2.55%)
Apr 8, 2026, 3:04 PM CST
SHE:002399 Revenue
In the year 2025, Shenzhen Hepalink Pharmaceutical Group had annual revenue of 5.48B CNY with 4.18% growth. Shenzhen Hepalink Pharmaceutical Group had revenue of 1.28B in the quarter ending December 31, 2025, with 6.00% growth.
Revenue
5.48B
Revenue Growth
+3.75%
P/S Ratio
2.77
Revenue / Employee
2.84M
Employees
1,926
Market Cap
15.18B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.48B | 220.06M | 4.18% |
| Dec 31, 2024 | 5.26B | -172.06M | -3.17% |
| Dec 31, 2023 | 5.43B | -1.73B | -24.14% |
| Jan 1, 2023 | 7.16B | 794.23M | 12.48% |
| Jan 1, 2022 | 6.37B | 1.03B | 19.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition